All manuscripts must be free from plagiarism contents. Manuscripts submitted to the Cellular, Molecular and Biomedical Reports (CMBR) will be screened for plagiarism using similarity check and plagiarism detection tools. All authors are suggested to use plagiarism detection software to check the similarity before submitting their manuscript to the journal. Editors check the plagiarism detection of manuscripts in the Cellular, Molecular and Biomedical Reports (CMBR) using the Grammarly detection software (, and iThenticate ( (Permissible level of plagiarism is 15%) to be assured about their originality and then rigorously peer-reviewed by international reviewers.

The journal will immediately reject papers leading to plagiarism or self-plagiarism. Whenever it is determined that the manuscript has not complied with the plagiarism rules, the article is rejected (before accepting) and if it has been published (after accepting), it will be removed from the published list and placed in the withdrawn list (returned articles because of Failure to observe plagiarism law).